Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension

  • S. M. Jin
  • , S. W. Park
  • , K. H. Yoon
  • , K. W. Min
  • , K. H. Song
  • , K. S. Park
  • , J. Y. Park
  • , I. B. Park
  • , C. H. Chung
  • , S. H. Baik
  • , S. H. Choi
  • , H. W. Lee
  • , I. K. Lee
  • , D. M. Kim
  • , M. K. Lee

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science